17.01.2014 Views

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

Invasive breast carcinoma - IARC

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A<br />

Fig. 2.29 Ovarian endometrioid adeno<strong>carcinoma</strong> arising from an endometriotic cyst. A This solid and cystic tumour forms polypoid structures. The patient had a synchronous<br />

endometrioid adeno<strong>carcinoma</strong> of the uterine corpus. B Well differentiated endometrioid adeno<strong>carcinoma</strong> is seen to the right and an endometriotic cyst on the left.<br />

B<br />

Endometrioid tumours<br />

Definition<br />

Tumours of the ovary, benign, low malignant<br />

potential or malignant, that closely<br />

resemble the various types of endometrioid<br />

tumours (epithelial and/or stromal) of<br />

the uterine corpus. Although an origin<br />

from endometriosis can be demonstrated<br />

in some cases, it is not required for the<br />

diagnosis.<br />

ICD-O codes<br />

Endometrioid adeno<strong>carcinoma</strong>,<br />

not otherwise specified 8380/3<br />

Variant with squamous<br />

differentiation 8570/3<br />

Ciliated variant 8383/3<br />

Oxyphilic variant 8290/3<br />

Secretory variant 8382/3<br />

Adenocarcinofibroma 8381/3<br />

Malignant müllerian<br />

mixed tumour 8950 / 3<br />

Adenosarcoma 8933/3<br />

Endometrioid stromal sarcoma 8930/3<br />

Endometrioid borderline tumour 8380/1<br />

Cystadenoma 8380/0<br />

Adenofibroma;<br />

cystadenofibroma 8381/0<br />

Endometrioid adeno<strong>carcinoma</strong><br />

Definition<br />

A malignant epithelial tumour of the ovary<br />

that closely resembles the common variant<br />

of endometrioid <strong>carcinoma</strong> of the uterine<br />

corpus. Although an origin from endometriosis<br />

can be demonstrated in some<br />

cases, it is not re q u i red for the diagnosis.<br />

Epidemiology<br />

Endometrioid <strong>carcinoma</strong>s account for<br />

10-20% of ovarian <strong>carcinoma</strong>s {1409,<br />

2489} and occur most commonly in<br />

women in the fifth and sixth decades of<br />

life {2773}.<br />

Aetiology<br />

Up to 42% of the tumours are associated<br />

with endometriosis in the same ovary or<br />

elsewhere in the pelvis {676,932,1927,<br />

2489,2287a} and 15-20% are associated<br />

with endometrial <strong>carcinoma</strong> {1477,1479,<br />

1683,3239}. These associations suggest<br />

that some endometrioid ovarian <strong>carcinoma</strong>s<br />

may have the same risk factors for<br />

their development as endometrial <strong>carcinoma</strong>s<br />

{613}. Patients whose tumours<br />

occur in association with endometriosis<br />

are 5-10 years younger on average than<br />

patients without associated ovarian<br />

endometriosis {2600}.<br />

Clinical features<br />

Like most ovarian <strong>carcinoma</strong>s, many endometrioid<br />

<strong>carcinoma</strong>s are asymptomatic.<br />

Some present as a pelvic mass, with or<br />

without pain and may be associated with<br />

endocrine symptoms secondary to stero i d<br />

h o rmone secretion by the specialized ovarian<br />

stroma {1790}. Serum CA125 is elevated<br />

in over 80% of the cases {946,1603}.<br />

Macroscopy<br />

The tumours, typically measuring 10-20<br />

cm in diameter, are solid, soft, friable or<br />

cystic with a fungating mass protruding<br />

into the lumen. They are bilateral in 28%<br />

of the cases.<br />

Tumour spread and staging<br />

Stage I <strong>carcinoma</strong>s are bilateral in 17% of<br />

the cases {2233}. The stage distribution of<br />

endometrioid <strong>carcinoma</strong>s differs from that<br />

of serous <strong>carcinoma</strong>s. According to the<br />

FIGO annual re p o rt, 31% of the tumours<br />

a re stage I; 20%, stage II; 38%, stage III;<br />

and 11%, stage IV {2233}.<br />

Histopathology<br />

Ovarian endometrioid <strong>carcinoma</strong>s closely<br />

resemble endometrioid <strong>carcinoma</strong>s of<br />

the uterine corpus. The well differentiated<br />

form shows round, oval or tubular glands<br />

lined by stratified nonmucin-containing<br />

epithelium. Cribriform or villoglandular<br />

patterns may be present. Squamous diff<br />

e rentiation occurs in 30-50% of the<br />

cases, often in the form of morules (cytologically<br />

benign-appearing squamous<br />

cells) {341,2605}. The designation<br />

"endometrioid <strong>carcinoma</strong> with squamous<br />

differentiation" (rather than adenoacanthoma<br />

and adenosquamous <strong>carcinoma</strong>)<br />

is favoured {2604,2605}. Aggregates of<br />

spindle-shaped epithelial cells are an<br />

occasional finding in endometrioid <strong>carcinoma</strong><br />

{2942}. Occasionally, the spindle<br />

cell nests undergo a transition to clearly<br />

recognizable squamous cells suggesting<br />

that the former may represent abortive<br />

squamous differentiation {2605}.<br />

Rare examples of mucin-rich, secretory,<br />

ciliated cell and oxyphilic types have<br />

been described {759,1187,2258}. In the<br />

mucin-rich variant glandular lumens and<br />

the apex of cells are occupied by mucin<br />

{2605}. The secretory type contains vacuolated<br />

cells resembling those of an<br />

130 Tumours of the ovary and peritoneum

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!